eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | non-alcoholic fatty liver disease |
| Comorbidity | C0032460|polycystic ovary syndrome |
| Sentences | 8 |
| PubMedID- 25136364 | Cannabinoid receptor 1 gene polymorphisms and nonalcoholic fatty liver disease in women with polycystic ovary syndrome and in healthy controls. |
| PubMedID- 26039829 | Prevalence of non-alcoholic fatty liver disease in women with polycystic ovary syndrome and its correlation with metabolic syndrome. |
| PubMedID- 23980352 | [effects of resolving method of chinese medicine on the lipid metabolism in polycystic ovary syndrome accompanied with non-alcoholic fatty liver disease]. |
| PubMedID- 24246334 | Obstructive sleep apnea predisposes to nonalcoholic fatty liver disease in patients with polycystic ovary syndrome. |
| PubMedID- 25973422 | In the same context, increased prevalence of nafld in patients with polycystic ovary syndrome is explained by androgen excess. |
| PubMedID- 25339805 | Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. |
| PubMedID- 25554608 | non-alcoholic fatty liver disease in women with polycystic ovary syndrome - clinical and metabolic aspects and lipoprotein lipase gene polymorphism. |
| PubMedID- 21029639 | Objective: to investigate the effect of obesity on nonalcoholic fatty liver disease (nafld) in women with polycystic ovary syndrome (pcos). |
Page: 1